New Lipid Lowering Therapies for Cardiovascular and Metabolic Diseases: Lessons from the Past and Future Challenges

This book illustrates some of the most recent research efforts that have been made in lowering plasma cholesterol levels in patients with CVD. Selected articles aimed to illuminate advances and urgent challenges in the management of CVD, including disease management using statin-combined therapeutic...

Full description

Bibliographic Details
Format: eBook
Language:English
Published: MDPI - Multidisciplinary Digital Publishing Institute 2019
Subjects:
HDL
Online Access:Open Access: DOAB: description of the publication
Open Access: DOAB, download the publication
LEADER 03457namaa2201009uu 4500
001 doab54599
003 oapen
005 20210211
006 m o d
007 cr|mn|---annan
008 210211s2019 xx |||||o ||| 0|eng d
020 |a 9783039216765 
020 |a 9783039216772 
020 |a books978-3-03921-677-2 
024 7 |a 10.3390/books978-3-03921-677-2  |2 doi 
040 |a oapen  |c oapen 
041 0 |a eng 
042 |a dc 
072 7 |a PS  |2 bicssc 
720 1 |a Bakillah, Ahmed  |4 aut 
245 0 0 |a New Lipid Lowering Therapies for Cardiovascular and Metabolic Diseases: Lessons from the Past and Future Challenges 
260 |b MDPI - Multidisciplinary Digital Publishing Institute  |c 2019 
300 |a 1 online resource (116 p.) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
506 0 |a Open Access  |f Unrestricted online access  |2 star 
520 |a This book illustrates some of the most recent research efforts that have been made in lowering plasma cholesterol levels in patients with CVD. Selected articles aimed to illuminate advances and urgent challenges in the management of CVD, including disease management using statin-combined therapeutic strategies. 
540 |a Creative Commons  |f https://creativecommons.org/licenses/by-nc-nd/4.0/  |2 cc  |u https://creativecommons.org/licenses/by-nc-nd/4.0/ 
546 |a English 
650 7 |a Biology, life sciences  |2 bicssc 
653 |a ABCA1 
653 |a acute coronary syndrome 
653 |a acute kidney injury 
653 |a anacetrapib 
653 |a apolipoprotein 
653 |a atherosclerosis 
653 |a atrial fibrillation 
653 |a cardiovascular disease 
653 |a cardiovascular disease (CVD) 
653 |a cardiovascular diseases 
653 |a cardiovascular risk 
653 |a ceramides 
653 |a cholesterol 
653 |a cholesteryl ester transfer protein 
653 |a circular RNA 
653 |a coronary artery bypass grafting 
653 |a diabetes 
653 |a dyslipidemia 
653 |a gene expression 
653 |a genetic 
653 |a HDL 
653 |a hepatic fibrosis 
653 |a hyperlipidemia 
653 |a inclisiran 
653 |a LDL subfractions 
653 |a lipids 
653 |a lipoproteins 
653 |a low-density lipoprotein cholesterol 
653 |a low-density lipoprotein-cholesterol (LDL-C) 
653 |a miRNA 
653 |a NAFLD 
653 |a NASH 
653 |a nonstatin 
653 |a NSTEMI 
653 |a nutrigenetics 
653 |a PCSK9 
653 |a pleiotropic actions 
653 |a proprotein convertase subtilisin-kexin type 9 (PCSK9) 
653 |a proprotein convertase subtilisin/kexin type 9 
653 |a reverse cholesterol transport 
653 |a risk stratification 
653 |a RNA-binding proteins 
653 |a sdLDL 
653 |a small interfering RNA (siRNA) 
653 |a sphingolipids 
653 |a sphingomyelin 
653 |a statin 
653 |a statins 
653 |a STEMI 
653 |a sterol 
653 |a stroke 
653 |a type 2 diabetes 
653 |a vaspin 
793 0 |a DOAB Library. 
856 4 0 |u https://directory.doabooks.org/handle/20.500.12854/54599  |7 0  |z Open Access: DOAB: description of the publication 
856 4 0 |u https://mdpi.com/books/pdfview/book/1720  |7 0  |z Open Access: DOAB, download the publication